1. Substance Abuse and Mental Health Services Administration. (2020). Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/ Accessed August 23, 2023.
2. Luo, F., Li, M. & Florence, C. State level economic costs of opioid use disorder and fatal opioid overdose—United States, 2017. MMWR 70(15), 541–546 (2021).
3. Lee, B., Zhao, W., Yang, K. C., Ahn, Y. Y. & Perry, B. L. Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007–2018. JAMA Netw. Open 4, e2036687 (2021).
4. Currie, J. M., Schnell, M. K., Schwandt, H. & Zhang, J. Prescribing of opioid analgesics and buprenorphine for opioid use disorder during the COVID-19 pandemic. JAMA Netw. Open 4(4), e216147 (2021).
5. Ghose, R., Forati, A. M. & Mantsch, J. R. Impact of the COVID-19 pandemic on opioid overdose death: A spatiotemporal analysis. J. Urban Health 99, 316–327 (2022).